-

BIOTECanada Announces Addition of Directors to Board of Directors

TORONTO--(BUSINESS WIRE)--Following the Annual General Meeting of BIOTECanada, the Board of Directors is announcing the election of three additional Directors to the Board. The new Directors include:

  • Colleen Coxson, Country Manager, Alnylam Pharmaceuticals
  • Rhonda Pacheco, President and General Manager, Eli Lilly Canada
  • Nancy Pei, Partner, Smart & Biggar

“On behalf of the BIOTECanada team and the member companies, I extend appreciation to the outgoing Directors John Norman (Partner Gowling WLG Canada LLP), and Shermaine Tilley, Managing Partner (CTI Life Sciences Fund) for their time and commitment to the Association,” commented Andrew Casey President and CEO BIOTECanada. “Canada’s biotech ecosystem is built on a reputation of strong scientific research and includes a diverse mix of early-stage companies, universities, incubators/accelerators, research centres, investors, and multinational pharmaceutical/biotech companies. I look forward to working with the Board as we continue our quest to grow Canada’s life sciences sector and biomanufacturing capacity including attracting investment and talent to the sector.”

The 2022-2023 BIOTECanada Board of Directors

  • Gordon C. McCauley, President and CEO AdMare BioInnovations (Chair)
  • Roberto Bellini, President & CEO, Bellus Health (Vice Chair)
  • Oliver Technow, CEO, BioVectra Inc. (Treasurer)
  • Andrew Casey, President & CEO, BIOTECanada (Secretary)
  • Norma Biln, CEO, Augurex
  • Neal Carter, President & Founder, Okanagan Specialty Fruits
  • Andrew Haigh, President and CEO, Adapsyn Bioscience
  • Alok Kanti, General Manager, Bayer Canada
  • Melissa Koomey, Vice President & General Manager, Gilead Sciences Canada
  • A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
  • Paul Petrelli, President & CEO, Jazz Pharmaceuticals
  • Tracey Ramsay, Vice President and General Manager, AbbVie Canada
  • Sanj Singh, President & CEO, Temple Therapeutics B.V.
  • Jamie Stiff, Managing Director, Genesys Capital
  • Ali Tehrani, Partner, Amplitude Ventures

 

Contacts

Nadine.Lunt@biotech.ca
613-793-6338

Industry:

BIOTECanada

Release Versions
EnglishFrench

Contacts

Nadine.Lunt@biotech.ca
613-793-6338

More News From BIOTECanada

BIOTECanada: Federal Budget Delivers Breakthrough Wins for Canada’s Life Sciences Sector

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada welcomes the federal budget’s focus on advancing Canada’s life sciences sector through investment and regulatory modernization. As Canada navigates a challenging global economy, the industry stands as a key driver of sustainable growth, high-value employment, and long-term economic resilience. Globally, governments are recognizing life sciences as a strategic sector for economic growth and national security, and Canada is well-positioned to capitali...

BIOTECanada Welcomes New President & CEO

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada announces Wendy Zatylny as incoming President & CEO of BIOTECanada, representing the biotechnology ecosystem in Canada....

BIOTECanada Welcomes Three New Members to its Board of Directors

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada, the national industry association representing the biotechnology ecosystem in Canada, is pleased to announce three new members joining the Board of Directors: Anne Woods, (Managing Director, Life Sciences, Banking at RBCx); Tamer Mohamed, (Founder & CEO at Aspect Biosystems); and Karen Heim, (Vice President and General Manager, Canada at Alexion Pharmaceuticals). These industry leaders bring a wealth of knowledge, experience, and leadership to...
Back to Newsroom